Muhammad Wasif Saif, Saravanan
Abstract
Pancreatic cancer is the fourth leading cause of cancer deaths. Since the majority of patients present with incurablemetastatic disease, novel imaging methods are needed to identify pancreatic cancer and assess response to therapy.Research presented at the 2013 American Society of Oncology (ASCO) Annual Meeting provided insight into potentialimaging methods. We discuss Abstracts #4049, #TPS4144, #TPS4146, and #E15069 in this paper.